Geode Capital Management, LLC Exagen Inc. Transaction History

Geode Capital Management, LLC

$1.39 Trillion
Q2 2025

A detailed history of Geode Capital Management, LLC transactions in Exagen Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 146,483 shares of XGN stock, worth $1.72 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

146,483

Previous 100,599 45.61%

Holding current value

$1.72 Million

Previous $361,000 183.1%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$3.93 - $7.71 $180,324 - $353,765	45,884 Added 45.61%	146,483 $1.02 Million
Q1 2025 May 13, 2025	BUY	$2.74 - $5.33 $6,965 - $13,548	2,542 Added 2.59%	100,599 $361,000
Q4 2024 Feb 12, 2025	BUY	$2.43 - $6.0 $25,374 - $62,652	10,442 Added 11.92%	98,057 $402,000
Q2 2024 Aug 09, 2024	BUY	$1.36 - $2.05 $8,203 - $12,365	6,032 Added 7.39%	87,615 $159,000
Q3 2023 Nov 13, 2023	BUY	$2.24 - $2.93 $14,745 - $19,288	6,583 Added 8.78%	81,583 $197,000
Q4 2022 Feb 13, 2023	SELL	$2.1 - $3.4 $350 - $567	-167 Reduced 0.22%	75,000 $180,000
Q2 2022 Aug 12, 2022	SELL	$4.18 - $7.74 $327,431 - $606,297	-78,333 Reduced 51.03%	75,167 $431,000
Q1 2022 May 13, 2022	BUY	$7.12 - $11.06 $19,053 - $29,596	2,676 Added 1.77%	153,500 $1.23 Million
Q4 2021 Feb 11, 2022	SELL	$8.97 - $14.08 $84,048 - $131,929	-9,370 Reduced 5.85%	150,824 $1.75 Million
Q3 2021 Nov 12, 2021	BUY	$10.25 - $15.21 $219,801 - $326,163	21,444 Added 15.46%	160,194 $2.18 Million
Q2 2021 Aug 13, 2021	BUY	$12.4 - $17.92 $691,907 - $999,918	55,799 Added 67.27%	138,750 $2.08 Million
Q1 2021 May 12, 2021	BUY	$13.9 - $22.0 $66,706 - $105,578	4,799 Added 6.14%	82,951 $1.45 Million
Q4 2020 Feb 12, 2021	BUY	$11.19 - $16.05 $12,387 - $17,767	1,107 Added 1.44%	78,152 $1.03 Million
Q3 2020 Nov 13, 2020	SELL	$10.56 - $16.69 $19,356 - $30,592	-1,833 Reduced 2.32%	77,045 $835,000
Q2 2020 Aug 13, 2020	BUY	$11.0 - $16.7 $147,147 - $223,395	13,377 Added 20.42%	78,878 $978,000
Q1 2020 May 14, 2020	BUY	$12.7 - $25.95 $140,576 - $287,240	11,069 Added 20.34%	65,501 $1.04 Million
Q4 2019 Feb 13, 2020	BUY	$12.61 - $28.48 $686,387 - $1.55 Million	54,432 New	54,432 $1.38 Million

Others Institutions Holding XGN

# of Institutions

Shares Held

9.08M

Call Options Held

Put Options Held

View Full List

About EXAGEN INC.

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $191M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

More about XGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Exagen Inc. Transaction History